Raymond James Financial Services Advisors’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $71.3K | Sell |
|
|||||
|
2023
Q4 | $62.6K | Sell |
|
|||||
|
2023
Q3 | $74.5K | Buy |
|
|||||
|
2023
Q2 | $71.4K | Sell |
|
|||||
|
2023
Q1 | $88.5K | Sell |
|
|||||
|
2022
Q4 | $55.7K | Sell |
|
|||||
|
2022
Q3 | $56K | Buy |
|
|||||
|
2022
Q2 | $42K | Buy |
|
|||||
|
2022
Q1 | $72K | Buy |
|
|||||
|
2021
Q4 | $95K | Sell |
|
|||||
|
2021
Q3 | $200K | Sell |
|
|||||
|
2021
Q2 | $191K | Buy |
|
|||||
|
2021
Q1 | $231K | Sell |
|
|||||
|
2020
Q4 | $179K | Sell |
|
|||||
|
2020
Q3 | $280K | Sell |
|
|||||
|
2020
Q2 | $376K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $477K | Buy |
|
|||||
|
2019
Q3 | $205K | Sell |
|
|||||
|
2019
Q2 | $214K | Sell |
|
|||||
|
2019
Q1 | $385K | Sell |
|
|||||
|
2018
Q4 | $634K | Buy |
|
|||||
|
2018
Q3 | $935K | Buy |
|
|||||
|
2018
Q2 | $877K | Buy |
|
|||||
|
2018
Q1 | $276K | Buy |
|
|||||
|
2017
Q4 | $203K | Buy |
|
|||||
|
2017
Q3 | $194K | Buy |
|
|||||
|
2017
Q2 | $131K | Buy |
|